THR

THR製品

All (15)
THR阻害剤 (3)
THR活性剤(2)
THR作動薬(4)
新製品

製品コード	製品名称	製品説明	文献中Selleckの製品使用例
S5726	T3 (Triiodothyronine)	T3 (Triiodothyronine) is a thyroid hormone that affects various physiological process in the body, including growth and development, metabolism, body temperature, and heart rate.This product is soluble but easy to precipitate after freezing in DMSO. NaOH is recommended as a stock solution.	Invest Ophthalmol Vis Sci, 2024, 65(4):43 Int J Mol Sci, 2023, 24(13)10838 Int J Mol Sci, 2023, 24(13)10838
S6663	Resmetirom (MGL-3196)	Resmetirom (MGL-3196, VIA-3196) is a liver-directed, orally active, selective thyroid hormone receptor β(THR-β) agonist with an EC50 of 0.21 μM,shows 28-fold selective for THR-β over THR-α in a functional assay.	Int J Mol Sci, 2023, 24(6)5843 Int J Mol Sci, 2023, 24(6)5843 Front Chem, 2022, 10:888587
S4217	Liothyronine Sodium	Liothyronine Sodium(Cytomel) is the most potent form of thyroid hormone acting on the body to increase the basal metabolic rate, affect protein synthesis.
S2599	L-Thyroxine (Levothyroxine)	L-Thyroxine (Levothyroxine) is a synthetic form of thyroxine and a hormone replacement drug.
S5193	L-Thyroxine sodium salt pentahydrate	L-Thyroxine (Levothyroxine, L-T4) sodium salt pentahydrate is a synthetic T4 hormone used to counterbalance hypothyroidism.
E4686^New	DCZ0415	DCZ0415 is a potent inhibitor of TRIP13. DCZ0415 impairs nonhomologous end joining repair and inhibits NF-κB activity. It triggers anti-myeloma effects both in vitro, and in vivo, and primary cells obtained from myeloma patients resistant to drugs.
E1924^New	TI17	TI17 is an inhibitor of thyroid hormone receptor-interacting protein Trip13. TI17 efficiently suppresses the proliferation of multiple myeloma (MM) cells and triggers cell cycle arrest and apoptosis. Trip13, an AAA-ATPase involved in double-strand break (DSB) repair, is targeted by TI17, leading to impaired function and heightened DNA damage.
E2877	dextrothyroxine sodium	Dextrothyroxine (D-T4) sodium, a sodium salt of D-T4, is a laevorotatory isomer of thyroxine used for thyroid related studies.
S0343	Eprotirome (KB2115)	Eprotirome (KB2115) is a liver-selective agonist of thyroid hormone receptor (TR). Eprotirome is investigated for the potential treatment of dyslipidemias and obesity.
S4185	Tiratricol	Tiratricol (also known as TRIAC or triiodothyroacetic acid) is a thyroid hormone analogue.
S3747	Levothyroxine (L-Thyroxine) sodium	Levothyroxine (L-Thyroxine) sodium is the major hormone derived from the thyroid gland. It is the agonist of Thyroid hormone receptor alpha and beta.
S6663	Resmetirom (MGL-3196)	Resmetirom (MGL-3196, VIA-3196) is a liver-directed, orally active, selective thyroid hormone receptor β(THR-β) agonist with an EC50 of 0.21 μM,shows 28-fold selective for THR-β over THR-α in a functional assay.	Int J Mol Sci, 2023, 24(6)5843 Int J Mol Sci, 2023, 24(6)5843 Front Chem, 2022, 10:888587
E2877	dextrothyroxine sodium	Dextrothyroxine (D-T4) sodium, a sodium salt of D-T4, is a laevorotatory isomer of thyroxine used for thyroid related studies.
S0343	Eprotirome (KB2115)	Eprotirome (KB2115) is a liver-selective agonist of thyroid hormone receptor (TR). Eprotirome is investigated for the potential treatment of dyslipidemias and obesity.
S3747	Levothyroxine (L-Thyroxine) sodium	Levothyroxine (L-Thyroxine) sodium is the major hormone derived from the thyroid gland. It is the agonist of Thyroid hormone receptor alpha and beta.
E4686^New	DCZ0415	DCZ0415 is a potent inhibitor of TRIP13. DCZ0415 impairs nonhomologous end joining repair and inhibits NF-κB activity. It triggers anti-myeloma effects both in vitro, and in vivo, and primary cells obtained from myeloma patients resistant to drugs.
E1924^New	TI17	TI17 is an inhibitor of thyroid hormone receptor-interacting protein Trip13. TI17 efficiently suppresses the proliferation of multiple myeloma (MM) cells and triggers cell cycle arrest and apoptosis. Trip13, an AAA-ATPase involved in double-strand break (DSB) repair, is targeted by TI17, leading to impaired function and heightened DNA damage.
S4185	Tiratricol	Tiratricol (also known as TRIAC or triiodothyroacetic acid) is a thyroid hormone analogue.
S5726	T3 (Triiodothyronine)	T3 (Triiodothyronine) is a thyroid hormone that affects various physiological process in the body, including growth and development, metabolism, body temperature, and heart rate.This product is soluble but easy to precipitate after freezing in DMSO. NaOH is recommended as a stock solution.	Invest Ophthalmol Vis Sci, 2024, 65(4):43 Int J Mol Sci, 2023, 24(13)10838 Int J Mol Sci, 2023, 24(13)10838
S4217	Liothyronine Sodium	Liothyronine Sodium(Cytomel) is the most potent form of thyroid hormone acting on the body to increase the basal metabolic rate, affect protein synthesis.
S6663	Resmetirom (MGL-3196)	Resmetirom (MGL-3196, VIA-3196) is a liver-directed, orally active, selective thyroid hormone receptor β(THR-β) agonist with an EC50 of 0.21 μM,shows 28-fold selective for THR-β over THR-α in a functional assay.	Int J Mol Sci, 2023, 24(6)5843 Int J Mol Sci, 2023, 24(6)5843 Front Chem, 2022, 10:888587
E2877	dextrothyroxine sodium	Dextrothyroxine (D-T4) sodium, a sodium salt of D-T4, is a laevorotatory isomer of thyroxine used for thyroid related studies.
S0343	Eprotirome (KB2115)	Eprotirome (KB2115) is a liver-selective agonist of thyroid hormone receptor (TR). Eprotirome is investigated for the potential treatment of dyslipidemias and obesity.
S3747	Levothyroxine (L-Thyroxine) sodium	Levothyroxine (L-Thyroxine) sodium is the major hormone derived from the thyroid gland. It is the agonist of Thyroid hormone receptor alpha and beta.
E4686^New	DCZ0415	DCZ0415 is a potent inhibitor of TRIP13. DCZ0415 impairs nonhomologous end joining repair and inhibits NF-κB activity. It triggers anti-myeloma effects both in vitro, and in vivo, and primary cells obtained from myeloma patients resistant to drugs.
E1924^New	TI17	TI17 is an inhibitor of thyroid hormone receptor-interacting protein Trip13. TI17 efficiently suppresses the proliferation of multiple myeloma (MM) cells and triggers cell cycle arrest and apoptosis. Trip13, an AAA-ATPase involved in double-strand break (DSB) repair, is targeted by TI17, leading to impaired function and heightened DNA damage.

THR阻害剤の選択性比較